Common Stock, Shares, Issued of HTG MOLECULAR DIAGNOSTICS, INC from 31 Dec 2014 to 31 Mar 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2014 to 31 Mar 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Common Stock, Shares, Issued for the quarter ending 31 Mar 2023 was 2,214,077, a 74% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 2,214,077 -6,369,176 -74% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 2,213,897 +1,581,557 +250% 31 Dec 2022 10-Q 11 May 2023 2023 Q1
Q3 2022 11,048,111 +3,534,378 +47% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 11,045,986 +3,634,512 +49% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 8,583,253 +2,323,996 +37% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 632,340 -4,567,657 -88% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 7,513,733 -63,565,225 -89% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 7,411,474 -59,682,209 -89% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 6,259,257 -55,936,860 -90% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 5,199,997 +1,327,315 +34% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 71,078,958 +13,047,728 +22% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 67,093,683 +38,386,636 +134% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 62,196,117 +33,579,484 +117% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 3,872,682 -24,712,767 -86% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 58,031,230 +29,551,889 +104% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 28,707,047 +292,523 +1% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 28,616,633 +257,708 +0.91% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 28,585,449 +14,655,686 +105% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 28,479,341 +15,972,126 +128% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 28,414,524 +17,056,200 +150% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 28,358,925 +20,298,238 +252% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 13,929,763 +5,989,796 +75% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 12,507,215 +5,446,946 +77% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 11,358,324 +4,305,971 +61% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 8,060,687 +1,054,370 +15% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 7,939,967 +1,094,329 +16% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q3 2016 7,060,269 +219,009 +3.2% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 7,052,353 +224,939 +3.3% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 7,006,317 +6,671,165 +1990% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 6,845,638 +6,511,635 +1950% 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q3 2015 6,841,260 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 6,827,414 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 335,152 31 Mar 2015 10-Q 08 Jun 2015 2015 Q1
Q4 2014 334,003 31 Dec 2014 10-K 25 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.